Defining the Next Generation of Digital Biomarkers in Metabolic Diseases

Digital biomarkers are at an inflection point. While early efforts have focused on disease monitoring, the field is now shifting toward digital phenotyping, leveraging high-frequency, real-world data and advanced analytics to generate deeper, more meaningful insights into patient health.

Join us for a roundtable discussion bringing together experts across the ecosystem to explore how digital biomarkers are evolving, and what new opportunities this shift unlocks, particularly in metabolic diseases.

The conversation will focus on: